TR

Thappali Ramaswamy Sethuraman Satheesh Manikandan

Active Director Director DIN 08947176
DIN 08947176 First appointment Mar 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2022
Shareholding value •••• Premium profile

About Thappali Ramaswamy Sethuraman Satheesh Manikandan

Data last updated:

Thappali Ramaswamy Sethuraman Satheesh Manikandan is a Director at Fenix Research Labs Private Limited (since 2022) and Director at Sirak Pharmaceuticals Private Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹14.58 Cr; the largest is Fenix Research Labs Private Limited at ₹11.62 Cr (FY 2025).

DIN 08947176
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2022
Oldest Company Age 18 yrs
Largest company Fenix Research Labs Private Limited · ₹11.62 Cr (FY 2025)
Combined revenue ₹14.58 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fenix Research Labs Private Limited U24239TG2008PTC059967
Director26 Aug 20222008₹11.62 Cr (FY 2025)Active
Director31 Mar 20222008₹2.97 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Sirak Pharmaceuticals Private Limited
Fenix Research Labs Private Limited
Premium access

Shareholding and investment profile for Thappali Ramaswamy Sethuraman Satheesh Manikandan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thappali Ramaswamy Sethuraman Satheesh Manikandan

Thappali Ramaswamy Sethuraman Satheesh Manikandan currently holds 2 directorships: Fenix Research Labs Private Limited (Director, since 26 Aug 2022, revenue ₹11.62 Cr (FY 2025)); Sirak Pharmaceuticals Private Limited (Director, since 31 Mar 2022, revenue ₹2.97 Cr (FY 2024)).

Thappali Ramaswamy Sethuraman Satheesh Manikandan was first appointed on 31 Mar 2022 as Director at Sirak Pharmaceuticals Private Limited.

The 2 current companies of Thappali Ramaswamy Sethuraman Satheesh Manikandan that report revenue have a combined latest revenue of ₹14.58 Cr: Fenix Research Labs Private Limited ₹11.62 Cr (FY 2025); Sirak Pharmaceuticals Private Limited ₹2.97 Cr (FY 2024).

The current boards of Thappali Ramaswamy Sethuraman Satheesh Manikandan's companies include Pranav Chirayu Amin (Fenix Research Labs Private Limited), Satya Kameswari Vakkalanka (Fenix Research Labs Private Limited), Shaunak Chirayu Amin (Fenix Research Labs Private Limited), Sita Samyukta Vakkalanka (Sirak Pharmaceuticals Private Limited), Swaroopkumar Venkata Satya Vakkalanka (Sirak Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available